Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjersti Flatmark

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targetingMads H Haugen, Kjetil Boye, Jahn Martin Nesland, et al.
Journal of Translational Medicine|July 9, 2024
Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancerChristin Lund-Andersen, Annette Torgunrud, Chakravarthi Kanduri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patientsKjersti Flatmark, Kristin Bjørnland, Hans Olaf Johannessen, et al.
British Journal of Cancer|October 13, 2022
Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancerSebastian Meltzer, Anne Negård, Kine M Bakke, et al.
Anticancer Research|July 11, 2006
DNA damage responses in cell cycle G2 phase and mitosis--tracking and targetingAnne Hansen Ree, Trond Stokke, Ase Bratland, et al.
Annals of Surgical Oncology|May 21, 2021
Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyEbbe Billmann Thorgersen, Jørund Asvall, Ida Storhaug Frøysnes, et al.
Oncoimmunology|June 20, 2026
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studiesCaroline Truntzer, Marion Thibaudin, Paula Anna Bousquet, et al.
Cancer Medicine|December 31, 2024
Enrichment of Cancer-Associated Fibroblasts, Macrophages, and Up-Regulated TNF-α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal MetastasisEirik Høye, Chakravarthi Kanduri, Annette Torgunrud, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 10, 2019
Laparoscopic versus open liver resection in the posterosuperior segments: a sub-group analysis from the OSLO-COMET randomized controlled trialDavit L Aghayan, Åsmund A Fretland, Airazat M Kazaryan, et al.
Acta Oncologica (Stockholm, Sweden)|April 10, 2018
Low dose-rate irradiation with [<sup>3</sup>H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft modelStine Gyland Mikalsen, Lars Tore Gyland Mikalsen, Joe Alexander Sandvik, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targetingMads H Haugen, Kjetil Boye, Jahn Martin Nesland, et al.
Journal of Translational Medicine|July 9, 2024
Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancerChristin Lund-Andersen, Annette Torgunrud, Chakravarthi Kanduri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patientsKjersti Flatmark, Kristin Bjørnland, Hans Olaf Johannessen, et al.
British Journal of Cancer|October 13, 2022
Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancerSebastian Meltzer, Anne Negård, Kine M Bakke, et al.
Anticancer Research|July 11, 2006
DNA damage responses in cell cycle G2 phase and mitosis--tracking and targetingAnne Hansen Ree, Trond Stokke, Ase Bratland, et al.
Annals of Surgical Oncology|May 21, 2021
Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyEbbe Billmann Thorgersen, Jørund Asvall, Ida Storhaug Frøysnes, et al.
Oncoimmunology|June 20, 2026
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studiesCaroline Truntzer, Marion Thibaudin, Paula Anna Bousquet, et al.
Cancer Medicine|December 31, 2024
Enrichment of Cancer-Associated Fibroblasts, Macrophages, and Up-Regulated TNF-α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal MetastasisEirik Høye, Chakravarthi Kanduri, Annette Torgunrud, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 10, 2019
Laparoscopic versus open liver resection in the posterosuperior segments: a sub-group analysis from the OSLO-COMET randomized controlled trialDavit L Aghayan, Åsmund A Fretland, Airazat M Kazaryan, et al.
Acta Oncologica (Stockholm, Sweden)|April 10, 2018
Low dose-rate irradiation with [<sup>3</sup>H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft modelStine Gyland Mikalsen, Lars Tore Gyland Mikalsen, Joe Alexander Sandvik, et al.
Pageof 14